Shandra Eisenga Human Cell and Tissue Product Safety Act
Health119-hr1082 — Shandra Eisenga Human Cell and Tissue Product Safety Act. Sponsored by Rep. Moolenaar, John R. [R-MI-2]. Introduced 2025-02-06. House bill. 119th Congress. Latest action: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Amendment Analysis None
Text Divergence
-0.0%
Text Versions
4
Introduced → Final
4,264 → 4,264 chars
This bill has multiple text versions on record, indicating active revision.
- Sponsor
- Rep. Moolenaar, John R. [R-MI-2] (R), MI
- Introduced
- 2025-02-06
- Committees
- Health, Education, Labor, and Pensions Committee; Energy and Commerce Committee
- Subjects
- Administrative law and regulatory procedures; Civil actions and liability; Congressional oversight; Department of Health and Human Services; Health programs administration and funding; Health promotion and preventive care; Organ and tissue donation and transplantation
- Latest Action
- Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
No roll-call vote data available for this bill.
Similar Bills
- 118-s3733 — Shandra Eisenga Human Cell and Tissue Product Safety Act 94% match 118th Congress
- 118-hr7188 — Shandra Eisenga Human Cell and Tissue Product Safety Act 93% match 118th Congress
- 118-hr3433 — RARE Act 38% match 118th Congress
- 119-hr1048 — DETERRENT Act 37% match
- 118-hr498 — SUPPORT for Patients and Communities Reauthorization Act 32% match 118th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis